UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-37601

 

 

DIMENSION THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

840 Memorial Drive

Cambridge, MA 02139

(617) 401-0011

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive officers)

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   ☒
Rule 12g-4(a)(2)   ☐
Rule 12h-3(b)(1)(i)   ☒
Rule 12h-3(b)(1)(ii)   ☐
Rule 15d-6   ☐
Rule 15d-22(b)   ☐

Approximate number of holders of record as of the certification or notice date:           1 holder          

Pursuant to the requirements of the Securities Exchange Act of 1934, Dimension Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: November 17, 2017      By:    /s/ Karah Parschauer
                 Karah Parschauer
                 Vice President and Secretary

 

 

 

Grafico Azioni DIMENSION THERAPEUTICS, INC. (NASDAQ:DMTX)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di DIMENSION THERAPEUTICS, INC.
Grafico Azioni DIMENSION THERAPEUTICS, INC. (NASDAQ:DMTX)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di DIMENSION THERAPEUTICS, INC.